Region Joenkoepings Laen

The Department of Ophtalmology at Region Joenkoepings Laen is conducting a study that evaluates whether topical dexamethasone eye drops can lower the number of infants who require conventional treatment for retinopathy of prematurity.

• Preventative eye‑drop therapy for premature infants
• Reduction of invasive laser or cryotherapy procedures
• Monitoring safety and visual outcomes

The trial involves a multidisciplinary team of 29 investigators and aims to improve early‑intervention strategies for this vulnerable population.

Researchers at the site are evaluating new immune‑targeted combination therapies for patients with advanced clear cell renal cancer and melanoma, focusing on improving survival outcomes.

• Comparison of novel combination regimens versus standard care
• Measurement of progression‑free survival
• Assessment of overall survival benefits
• Exploration of adjuvant strategies after surgery

With 29 investigators participating, the program seeks to bring more effective systemic options to patients with these high‑risk cancers.

The clinic is running a comparative trial of gemcitabine versus mitomycin as adjuvant intravesical therapy for non‑muscle invasive bladder cancer at intermediate risk of recurrence.

• Direct comparison of two instillation agents
• Evaluation of recurrence‑free survival
• Focus on patients after transurethral tumor resection
• Safety and tolerability monitoring

This research supports the goal of reducing bladder cancer recurrence and improving quality of life for patients treated at the Jönköping facility.